Patents by Inventor Sadaaki Iwanaga

Sadaaki Iwanaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6077946
    Abstract: This invention relates to a DNA shown by SEQ ID No. 1 and an amino acid sequence coded by said DNA. This invention also relates to a DNA and an amino acid sequence of subunit a of (1.fwdarw.3)-.beta.-glucan sensitive factor derived from amebocytes of horseshoe crab and have potent affinity to (1.fwdarw.3)-.beta.-D-glucan in cell walls of fungi. Therefore, the invention is useful for the diagnosis of fungal diseases and as antimicrobial or eradicating agent of fungi in combination with an antifungal agent.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: June 20, 2000
    Assignee: Seikagaku Corporation
    Inventors: Sadaaki Iwanaga, Tatsushi Muta, Noriaki Seki, Toshio Oda
  • Patent number: 5965725
    Abstract: The present invention relates to polypeptide having a primary structure of amino acid sequence shown by Sequence List Sequence No. 1 and DNA encoding for the polypeptide. The polypeptide is obtainable by following steps (1)-(3):Step (1): extracting small granule fraction of homocytes of horseshoe crab with a buffer containing protein denaturing agent and chelating agent,Step (2): subjecting said extract to reverse phase high performance liquid chromatography,Step (3): eluting by concentration gradient elution with a hydrophobic organic solvent.Also, the polypeptide is produced by chemical synthesis. The polypeptide has similar chemical structure to defensin and is useful as gargles, disinfectants, antiseptics or antimicrobials.
    Type: Grant
    Filed: February 3, 1998
    Date of Patent: October 12, 1999
    Assignee: Seikagaku Kogyo Kabushiki Kaisha
    Inventors: Sadaaki Iwanaga, Shun-ichiro Kawabata, Tetsu Saito
  • Patent number: 5861378
    Abstract: The present invention relates to polypeptide having a primary structure of amino acid sequence shown by Sequence List Sequence No. 1 and DNA encoding for the polypeptide. The polypeptide is obtainable by following steps (1)-(3):Step (1): extracting small granule fraction of homocytes of horseshoe crab with a buffer containing protein denaturing agent and chelating agent,Step (2): subjecting said extract to reverse phase high performance liquid chromatography,Step (3): eluting by concentration gradient elution with a hydrophobic organic solvent.Also, the polypeptide is produced by chemical synthesis. The polypeptide has similar chemical structure to defensin and is useful as gargles, disinfectants, antiseptics or antimicrobials.
    Type: Grant
    Filed: July 21, 1995
    Date of Patent: January 19, 1999
    Assignee: Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corp.)
    Inventors: Sadaaki Iwanaga, Shun-ichiro Kawabata, Tetsu Saito
  • Patent number: 5795962
    Abstract: This invention relates to a DNA shown by SEQ ID No. 1 and an amino acid sequence coded by said DNA. This invention also relates to a DNA and an amino acid sequence of subunit a of (1.fwdarw.3)-.beta.-D-glucan sensitive factor derived from amebocytes of horseshoe crab and have potent affinity to (1.fwdarw.3)-.beta.-D-glucan in cell walls of fungi. Therefore, the invention is useful for the diagnosis of fungal diseases and as antimicrobial or eradicating agent of fungi in combination with an antifungal agent.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: August 18, 1998
    Assignee: Seikagaku Kogyo Kabushiki Kaisha
    Inventors: Sadaaki Iwanaga, Tatsushi Muta, Noriaki Seki, Toshio Oda
  • Patent number: 5760177
    Abstract: The invention provides a lipopolysaccharide (LPS) binding protein isolated from horseshoe crab. The LPS binding protein is isolated by (i) extracting the hemocyte membrane fraction of horseshoe crab with a polyethylene glycol ether type nonionic surface active agent in the presence of Ca ions, (ii) combining the extract with immobilized LPS under conditions that permit the LPS binding protein to bind the immobilized LPS to produce an LPS-LPS binding protein complex, and (iii) harvesting the LPS binding protein released from the complex in the presence of a chelating agent. The isolated LPS binding protein has a molecular weight of about 27,000 daltons as determined by SDS polyacrylamide gel electrophoresis and is operative to bind a lipopolysaccharide endotoxin. Accordingly, the isolated LPS binding protein can be used for detecting endotoxin and/or removing endotoxin from an injectable medicine.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: June 2, 1998
    Assignee: Seikagaku Kogyo Kabushiki Kaisha
    Inventors: Sadaaki Iwanaga, Shunichiro Kawabata, Tetsu Saito
  • Patent number: 5416194
    Abstract: This invention relates to a novel polypeptide represented by the formula: ##STR1## wherein Lys represents lysine, Trp tryptophan, Cys cystine, Phe phenylalanine, Arg arginine, Val valine, Tyr tyrosine, Gly glycine, Ile isoleucine and X a hydroxyl group or an amino group), its analogue and a method for preparing the same.The polypeptide exhibits strong affinity for lipopolysaccharide, and is useful for removing endotoxin and as a therapeutic agent of bacterial infections, and a method for preparing the same.
    Type: Grant
    Filed: August 7, 1992
    Date of Patent: May 16, 1995
    Assignee: Seikagaku Kogyo Co., Ltd.
    Inventors: Takanori Nakamura, Sadaaki Iwanaga
  • Patent number: 5068314
    Abstract: This invention relates to a novel polypeptide represented by the formula: ##STR1## (wherein Lys represents lysine, Trp tryptophan, Cys cystine, Phe phenylalanine, Arg arginine, Val valine, Tyr tyrosine, Gly glycine, Ile isoleucine and X a hydroxyl group or an amino group), its analogue and a method for preparing the same.The polypeptide exhibits strong affinity for lipolysaccharide, and is useful for removing endotoxin and as a therapeutic agent of bacterial infections.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: November 26, 1991
    Assignee: Seikagaku Kogyo Co. Ltd.
    Inventors: Takanori Nakamura, Sadaaki Iwanaga, Motonori Ohno, Kyosuke Miyazaki
  • Patent number: 4188264
    Abstract: A process for determining a bacterial endotoxin, which comprises contacting an assay sample with (A) a material selected from the group consisting of an amoebocyte lysate of horseshoe crab an a pro-clotting enzyme separated from the lysate, and (B) a peptide-type substrate of the formula (R.sub.1 --Gly--Arg--R.sub.2), wherein R.sub.1 represents a member selected from the group consisting of an L-amino acid moiety whose N-terminal is protected by a protective group, a peptide moiety consisting of an L-amino acid and protected by a protective group at its N-terminal, a D-amino acid substituted L-amino acid moiety, and a D-amino acid substituted peptide moiety consisting of an L-amino acid, and is bonded to the amino group of the glycine moiety expressed by Gly through a peptide bond; and R.sub.
    Type: Grant
    Filed: November 1, 1977
    Date of Patent: February 12, 1980
    Assignee: Seikagaku Kogyo Co. Ltd.
    Inventors: Sadaaki Iwanaga, Takashi Morita, Shin Nakamura, Kenji Takahashi, Makoto Niwa